AI to the rescue: boosting colon cancer screening in china
NCT ID NCT07261059
First seen Jan 06, 2026 · Last updated Apr 24, 2026 · Updated 16 times
Summary
This study tests whether an AI-powered care program can encourage more high-risk adults (ages 40-64) in China to get a colonoscopy, the gold standard for colorectal cancer screening. About 400 participants will be split into two groups: one receives standard care, the other gets extra AI-assisted support from a team of specialists and general practitioners. The goal is to see if the AI approach improves screening knowledge, health beliefs, and actual colonoscopy rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.